Donal ODwyer - Cardiex Independent Non-Executive Chairman of the Board

<div class='circular--portrait' style='background:#000000;color: #f2f2f2;font-size:3em;padding-top: 38px;;'>AMD</div>
AMDHF -- USA Stock  

USD 0.005  0.00  0.00%

  Chairman
Mr. Donal Paul ODwyer, BEng, MBA, is no longer Independent NonExecutive Chairman of the Board of AtCor Medical Holdings Limited effective 26 February 2019. He is Independent director of the Group since September 2004 and chairman since November 2004. Extensive experience in the cardiovascular sector. Prior to joining the AtCor Board he was worldwide President of Cordis Cardiology, the cardiology division of Johnson Johnson. He is the Nonexecutive director for 3 other listed public companies Cochlear Ltd, Mesoblast Ltd and Fisher Paykel Healthcare Corporationrationration Ltd.
Age: 63  Chairman Since 2004  MBA    
61 2 9874 8761  http://cardiex.com

Cardiex Management Efficiency

Cardiex has return on total asset (ROA) of (28.75) % which means that it has lost $28.75 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (54.94) %, meaning that it generated substantial loss on money invested by shareholders. Cardiex management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities.

Similar Executives

Found 12 records

CHAIRMAN Since

Philippe LemaitreSun Hydraulics
2013
Jon MoellerProcter Gamble
2017
Alan LafleyProcter Gamble
N/A
Peter ScherJP Morgan Chase
2017
David TaylorProcter Gamble
2016
Fritz GerberROCHE HOLDINGS AG
2004
James DimonJP Morgan Chase
2018
Jianqing JiangINDUSTRIAL COMMERCIAL BK
2005
Huiman YiINDUSTRIAL COMMERCIAL BK
2016
Art LevinsonApple Inc
2011
Arthur LevinsonApple Inc
2011
Andre HoffmannROCHE HOLDINGS AG
N/A

Company Summary

CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. CardieX Limited was incorporated in 2005 and is based in Sydney, Australia. Cardiex is traded on BATS Exchange in the United States.Cardiex [AMDHF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Cardiex Leadership Team

Rhonda Welch, Vice President of Global Marketing
David Brookes, Independent Non-Executive Director
Mark Harding, VP of Global Marketing and International Sales - Atcor Medical Pty Ltd
Niall Cairns, Non-Executive Director
Chris Dax, Vice President - Operations
Peter Jenkins, Independent Non-Executive Director
Craig Cooper, CEO, Executive Director
Duncan Ross, CEO, Managing Director, Executive Director
Randall Nelson, Independent Non-Executive Director
Douglas Kurschinski, Sr. VP of Atcor Medical Inc and General Manager of Atcor Medical Inc
Michael ORourke, Non-Executive Director
Donal ODwyer, Independent Non-Executive Chairman of the Board
Peter Manley, CFO, Company Secretary

Stock Performance Indicators

Current Sentiment - AMDHF

Cardiex Investor Sentiment

Macroaxis portfolio users are unresponsive in their sentiment towards investing in Cardiex. What is your opinion about investing in Cardiex? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Cardiex Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Cardiex and Apple Inc. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Please continue to Trending Equities. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page